IGI Global Offers Free Access to "The Ethics of Neuroenhancement: Smart Drugs, Competition and Society"

Can smart drugs enhance brain power? Recent studies show that "smart drugs" are becoming increasingly popular among today's academics and researchers, raising important questions about whether cognitive enhancement is morally objectionable.

During April, IGI Global is offering free access to the article "The Ethics of Neuroenhancement: Smart Drugs, Competition and Society." In the article, Dr. Nils-Frederic Wagner, University of Ottawa, Canada and Carleton University; Dr. Jeffrey Robinson, Royal Ottawa Health Care Group; and Dr. Christine Wiebking, Department of Sociology of Physical Activity and Health, University of Potsdam, Germany, explore more of the ethical dilemmas surrounding these suspect meds. The article is an attempt to articulate the moral unease, and poses an argument for why the authors believe cognitive enhancement to be morally objectionable.

IGI Global is one of the leading publishers of books, journals, and databases on information and computer science technology applied to business and public administration, engineering, education, medicine and healthcare, and social science. FREE lifetime e-access with all print journal subscriptions is now available.

For more information on IGI Global products, contact Christopher Burke, burke@amigos.org or 800-843-8482, ext. 2805.